Search results
Hunter Biden's exes are called as witnesses in his federal gun trial
WPXI· 1 hour agoWILMINGTON, Del. — (AP) — Hunter Biden's ex-wife was called Wednesday to testify in his federal gun...
Hunter Biden gun trial hears from FBI agent as First Lady looks on
AFP via Yahoo News· 3 hours agoJurors at Hunter Biden's trial heard testimony Wednesday from an FBI agent who investigated the US...
FDA to vote Wednesday on COVID-19 shots to target emerging variants in US for 2024-25
Detroit News· 15 hours agoA U.S. Food and Drug Administration advisory committee will meet Wednesday to recommend a COVID-19...
Madrigal, Akero, 89bio Tumble After Lilly's Weight-Loss Drug Tackles MASH
Investor's Business Daily· 3 hours agoMadrigal stock soared 268% on Dec. 19, 2022, after the company said 30% of patients who received its...
Marjorie Taylor Greene Gave A Bizarre Animal Testing Rant Against Fauci. Here’s The Truth.
HuffPost via Yahoo News· 47 minutes agoThe congresswoman’s attempt to blame Dr. Anthony Fauci for animal testing in Africa may have been...
Playbook PM: Three big spending blitzes that could shape 2024
Politico· 45 minutes agoThey’ll air in six key swing states...
Pennsylvania Couple Charged After Child Died Injesting Their Fentanyl-Laced Drugs
Shore NewsNetwork· 28 minutes agoIn a tragic case of neglect, Holly Back, 40, and Mousa Hawa, 41, have been arrested and charged with multiple crimes related to the death of an 8-year-old child due to exposure to illegal drugs ...
Eli Lilly details NASH effects of weight loss drug (NYSE:LLY)
Seeking Alpha· 6 hours agoEli Lilly (LLY) posts detailed mid-stage results highlighting the benefits of its weight loss drug...
Arrivent Biopharma enters into cancer drug development collaboration valued at up to $615M -...
The Business Journals· 59 minutes agoArriVent Biopharma has made a deal with a Chinese firm on a drug development collaboration...
Be Bio’s haemophilia B treatment gains FDA orphan drug status
Pharmaceutical Technology via Yahoo Finance· 7 hours agoThe company is preparing to launch a Phase I/II BeCoMe-9 study of BE-101 in adults with severe or...